EVA Live Launches NeuroServer After Nasdaq Uplisting, Considers Share Buybacks
EVA Live uplisted to Nasdaq and launched NeuroServer, its next-generation AI advertising platform, transitioning into full commercialization. The company withdrew its Form S-1 registration, is evaluating a share repurchase program and has bolstered teams to scale sales, reflecting disciplined capital management and confidence in long-term value.
1. Nasdaq Uplisting and NeuroServer Launch
EVA Live achieved a successful uplisting to the Nasdaq Stock Market and officially launched NeuroServer, its next-generation AI-driven advertising platform. This platform marks the shift from technology development to full-scale commercialization aimed at driving core revenue growth across global digital ad markets.
2. Withdrawal of Form S-1 and Capital Focus
The company withdrew its previously filed Form S-1 registration to concentrate on executing its growth strategy with disciplined capital management. Management emphasized maintaining financial flexibility to pursue value-enhancing opportunities while preserving operational efficiency.
3. Potential Share Repurchase Program
EVA Live's board is evaluating a potential share repurchase program subject to approval, market conditions, and regulatory requirements. This initiative reflects management's confidence in the company's long-term outlook and current financial position.
4. Team Expansion to Support Growth
Following the Nasdaq uplisting, EVA Live expanded its engineering, product, and business development teams by hiring experienced industry professionals. These additions are intended to accelerate sales scaling, product development, and customer support to meet growing market demand.